Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Revenue (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Revenue for 3 consecutive years, with $1.0 million as the latest value for Q1 2022.

  • Quarterly Revenue fell 82.46% to $1.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2022, down 86.84% year-over-year, with the annual reading at $1.0 million for FY2022, 86.84% down from the prior year.
  • Revenue for Q1 2022 was $1.0 million at SELLAS Life Sciences, down from $1.9 million in the prior quarter.
  • The five-year high for Revenue was $5.7 million in Q1 2021, with the low at $1.0 million in Q1 2022.
  • Average Revenue over 3 years is $2.6 million, with a median of $1.9 million recorded in 2020.
  • Peak annual rise in Revenue hit 82.46% in 2022, while the deepest fall reached 82.46% in 2022.
  • Over 3 years, Revenue stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then tumbled by 47.37% to $1.0 million in 2022.
  • According to Business Quant data, Revenue over the past three periods came in at $1.0 million, $1.9 million, and $5.7 million for Q1 2022, Q2 2021, and Q1 2021 respectively.